财经
财经
首页500124 • BOM
瑞迪制药
₹1,200.80
11月4日, GMT+5:30 16:01:26 · INR · BOM · 免责声明
昨日收盘价
₹1,196.45
当日价格范围
₹1,193.20 - ₹1,204.00
年度波幅
₹1,025.90 - ₹1,404.60
市值
9986.30亿 INR
平均交易量
24.07万
市盈率
17.34
股息率
0.67%
主要交易所
NSE
市场资讯
简介
Dr. Reddy's Laboratories Ltd. is an Indian multinational pharmaceutical company based in Hyderabad, with U.S. headquarters in East Brunswick, New Jersey. The company was founded by Kallam Anji Reddy, who previously worked in the mentor institute Indian Drugs and Pharmaceuticals Limited. Dr. Reddy manufactures and markets a wide range of pharmaceuticals in India and overseas. The company produces over 190 medications, 60 active pharmaceutical ingredients for drug manufacture, diagnostic kits, critical care, and biotechnology. Dr. Reddy's began as a supplier to Indian drug manufacturers, but it soon started exporting to less-regulated markets that had the advantage of not having to spend time and money on a manufacturing plant that would gain approval from a drug licensing body such as the U.S. Food and Drug Administration. By the early 1990s, the expanded scale and profitability from these unregulated markets enabled the company to begin focusing on getting approval from drug regulators for their formulations and bulk drug manufacturing plants – in more-developed economies. This allowed their movement into regulated markets such as the US and Europe. By 2007, Dr. Wikipedia
成立时间
1984
员工数量
27,811
搜索
清除搜索内容
关闭搜索框
Google 应用
主菜单